Sign in
GUTS Stock Price, Chart, Stats & News
Fractyl Health, Inc. Common Stock
Save
60.43M
Market cap
–
Current P/E
–
Forward P/E
GUTS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -116.11% |
ROE | 10146.05% |
D/E | 6.52x |
Interest coverage ratio | – |
GUTS valuation
P/E | – |
P/S | – |
P/B | 3.60x |
P/CF | -0.38x |
P/FCF | -0.36x |
P/OCF | -0.38x |
PEG | 0.08x |
EV multiple | -0.44x |
About
Fractyl Health, Inc. is a biopharmaceutical firm dedicated to advancing treatments for type 2 diabetes (T2D) and obesity. Among its offerings is the Revita DMR System (Revita), an outpatient procedure engineered to provide lasting modification of duodenal dysfunction. This condition often arises from diets high in fat and sugar, playing a role in the onset of T2D and obesity in individuals.
Similar securities
Based on sector and market capitalization
Report issue